Potential Reduction in Adverse Events and Cost with Novel Anticoagulants among Patients with Acute Limb Ischemia

BACKGROUND: Acute limb ischemia (ALI) is associated with significant morbidity and mortality. Novel anticoagulants reduce adverse events among patients with peripheral artery disease, though the potential effect of these therapies is unclear in patients with ALI. The present study thus sought to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Freeman, Scott, Williams, Piper, Barón, Anna E., Plomondon, Mary E., Waldo, Stephen W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197665/
https://www.ncbi.nlm.nih.gov/pubmed/35712525
http://dx.doi.org/10.1155/2022/3786815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197665/
https://www.ncbi.nlm.nih.gov/pubmed/35712525
http://dx.doi.org/10.1155/2022/3786815

Ejemplares similares